The Perceived Mismatch Between Dose Recommendations of PKI's and the Clinical Practice
NCT06402812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2024-05-07
Summary
A qualitative research study will be conducted using semi-structured interviews. The target population includes regulators involved in the registration of PKIs and healthcare professionals who use PKIs in clinical practice. Participants will be recruited until a rich understanding of the subject is reached.
Conditions
Interventions
- OTHER
-
Interview
A qualitative research study will be conducted using semi-structured interviews. The target population includes regulators involved in the registration of PKIs and healthcare professionals who use PKIs in clinical practice. Participants will be recruited until a rich understanding of the subject is reached.
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Esther Broekman, MD · University Medical Center Groningen
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-02-06
- Primary Completion
- 2024-03-01
- Completion
- 2024-03-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
NCT00588835 ·Status: TERMINATED ·Phase: PHASE4
-
A Five-Year Quality of Life Study for Cancer Patients
NCT01539148 ·Status: UNKNOWN
-
Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer
NCT06469957 ·Status: COMPLETED
-
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
NCT04803305 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines
NCT00838370 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
NCT01317550 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
NCT05183126 ·Status: RECRUITING ·Phase: PHASE4
-
Optimizing the Management of Patients With Oral Therapy
NCT03623490 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics and Metabolism Study in Healthy Male Participants
NCT03247283 ·Status: COMPLETED ·Phase: PHASE1
-
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
NCT00905658 ·Status: UNKNOWN ·Phase: PHASE2
-
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
NCT00901264 ·Status: COMPLETED
-
Pharmacogenomic Testing to Personalize Supportive Oncology
NCT04500301 ·Status: COMPLETED ·Phase: NA
-
Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors
NCT03257969 ·Status: RECRUITING ·Phase: NA
-
Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00003242 ·Status: COMPLETED ·Phase: PHASE1
-
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer
NCT00059943 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases
NCT01248429 ·Status: COMPLETED
-
Pilot Study of a Pharmacy Intervention for Older Adults With Cancer
NCT02871115 ·Status: COMPLETED ·Phase: NA
-
Cancer Related Fatigue in Patients Receiving Chemotherapy
NCT00261534 ·Status: UNKNOWN
-
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
NCT05955924 ·Status: RECRUITING ·Phase: PHASE3
-
Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors
NCT00606125 ·Status: COMPLETED ·Phase: PHASE1
-
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
NCT00005590 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Boosting of Osimertinib
NCT03858491 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Food-effect on Alectinib Pharmacokinetics
NCT05710133 ·Status: COMPLETED ·Phase: NA